Altered glycosylation, such as changes in branching, fucosylation, and sialylation of the molecule was described in several cancer types, highlighting the relevance of AGP as a promising biomarker for malignant diseases [12,13,14,15]. This evidence concerns the gene ATP5MK and cancer.